CLINICAL_TRIALS
withdrawal
· 2025-02-03
Clinical Trial Update: PRISMA-PET - Primary Staging of Prostate Cancer With PSMA [NA]
Summary
The PRISMA-PET trial for primary staging of prostate cancer using PSMA imaging has been terminated. Sponsor Odense University Hospital.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Odense University Hospital | Conditions: Prostate Cancer | NA | Status: TERMINATED